Role of adiponectin in mediating the association of osteocalcin with insulin resistance and type 2 diabetes: A cross sectional study in pre- and post-menopausal women

Archives of Physiology and Biochemistry

Volumn 120, Issue 2, 2014, Pages 73-79

  Choudhury, Anil Baran ^a   Sarkar, Purnima Dey ^b   Sakalley, Dilip K ^a   Petkar, Sudhakar B ^c  

^a NSCB MEDICAL COLLEGE   (India)

^b MGM MEDICAL COLLEGE   (India)

^c People s College of Medical Sciences and Research Centre   (India)

Author keywords

Adiponectin; Glucose homeostasis; HOMA IR; Insulin resistance; Osteocalcin; Type 2 diabetes

Indexed keywords

ADIPONECTIN; OSTEOCALCIN;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE;

ADIPONECTIN; ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OSTEOCALCIN; POSTMENOPAUSE; PREMENOPAUSE;

EID: 84907926548     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2013.877488     Document Type: Article

References (36)

1. Berner HS, Lyngstadaas SP, Spahr A, et al. (2004). Adiponectin and its receptors are expressed in bone-forming cells. Bone, 35:842-9.
2. Bulló M, Moreno-Navarrete JM, Fernández-Real JM, Salas-Salvadó J. (2012). Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and b cell function in elderly men at high cardiovascular risk. Am J Clin Nutr, 95:249-55.
3. Chen L, Li Q, Yang Z, et al. (2013). Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese. Diabet Med, 30:309-17.
4. Daimon M, Oizumi T, Saitoh T, et al. (2003). Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: The Funagata study. Diabetes Care, 26: 2015-20.
5. Das SK, Elbein SC. (2007). The search for type 2 diabetes susceptibility loci: The chromosome 1q story. Curr Diab Rep, 7:154-64.
6. Das SK, Sharma NK, Elbein SC. (2010). Analysis of osteocalcin as a candidate gene for type 2 diabetes (T2D) and intermediate traits in Caucasians and African Americans. Dis Markers, 28:281-6.
7. Eastell R, Ebeling PR. (2009). Bone turnover markers: A key tool for understanding osteoporosis. Osteoporos Int, 20:S237-8.
8. Ferron M, Hinoi E, Karsenty G, Ducy P. (2008). Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild type mice. Proc Natl Acad Sci USA, 105:5266-70.
9. Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 18: 499-502.
10. Gravenstein KS, Napora JK, Short RG, et al. (2011). Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism. J Clin Endocrinol Metab, 96:E884-90.
11. Griesmacher A, Peichl P, Pointinger P, et al. (1997). Biochemical markers in menopausal women. Scand J Clin Lab Invest Suppl, 227: 64-72.
12. Hauschka PV, Lian JB, Cole DE, Gundberg CM. (1989). Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev, 69:990-1047.
13. Heliövaara MK, Strandberg TE, Karonen SL, Ebeling P. (2006). Association of serum adiponectin concentration to lipid and glucose metabolism in healthy humans. Horm Metab Res, 38:336-40.
14. Hwang YC, Jeong IK, Ahn KJ, Chung HY. (2012). Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int, 23:1337-42.
15. Hwang YC, Jee JH, Jeong IK, et al. (2012). Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: Mean 8.4-year retrospective follow-up study. Diabetes Care, 35:1919-24.
16. Im JA, Yu BP, Jeon JY, Kim SH. (2008). Relationship between osteocalcin and glucose metabolism in post-menopausal women. Clin Chim Acta, 396:66-9.
17. Kanazawa I, Yamaguchi T, Yamamoto M, et al. (2009). Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab, 94:45-9.
18. Kanazawa I, Yamaguchi T, Yano S, et al. (2007). Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol, 8:51. doi: 10.1186/1471-2121-8-51.
19. Kim S, Lee JY, Im JA, et al. (2013). Association between serum osteocalcin and insulin resistance in post-menopausal, but not premenopausal, women in Korea. Menopause, 20:1061-6.
20. Lee HW, Kim SY, Kim AY, et al. (2009). Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells, 27:2254-62.
21. Lee NK, Sowa H, Hinoi E, et al. (2007). Endocrine regulation of energy metabolism by the skeleton. Cell, 130:456-69.
22. Lee SW, Jo HH, Kim MR, et al. (2012). Association between obesity, metabolic risks and serum osteocalcin level in post-menopausal women. Gynecol Endocrinol, 28:472-7.
23. Mantzoros CS, Li T, Manson JE, Hu FB. (2005). Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab, 90:4542-8.
24. Matsui S, Yasui T, Tani A, et al. (2013). Associations of estrogen and testosterone with insulin resistance in pre- and post-menopausal women with and without hormone therapy. Int J Endocrinol Metab, 11:65-70.
25. Matthews DR, Hosker JP, Rudenski AS, et al. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28:412-19.
26. Pittas AG, Harris SS, Eliades M, et al. (2009). Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab, 94:827-32.
27. Sarkar PD, Choudhury AB. (2012). Relationship of serum osteocalcin levels with blood glucose, insulin resistance and lipid profile in central Indian men with type 2 diabetes. Arch Physiol Biochem, 118: 260-4.
28. Sarkar PD, Choudhury AB. (2013). Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients. Eur Rev Med Pharmacol Sci, 17:1631-5.
29. Scherer PE, Williams S, Fogliano M, et al. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 270:26746-9.
30. Shea MK, Gundberg CM, Meigs JB, et al. (2009). Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr, 90:1230-35.
31. Sheng L, Cao W, Cha B, et al. (2013). Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol, 12:22. doi: 10.1186/1475-2840-12-22.
32. Spranger J, Kroke A, Möhlig M, et al. (2003). Adiponectin and protection against type 2 diabetes mellitus. Lancet, 361:226-8.
33. Sumarac-Dumanovic M, Milin J, Stamenkovic-Pejkovic D, et al. (2012). Association between osteocalcin and insulin resistance in obese women. Endocrine Abstracts, 29:1248.
34. World Health Organization. (1999). Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization.
35. World Health Organization Scientific Group. (1981). Research on the menopause. Technical Report Series 670. Geneva: World Health Organization.
36. Zhou M, Ma X, Li H, et al. (2009). Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol, 161:723-9.